Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Redox-responsive nanoassembly restrained myeloid-derived suppressor cells recruitment through autophagy-involved lactate dehydrogenase A silencing for enhanced cancer immunochemotherapy
Chunyu Xia, Man Li, Guang‐Yao Ran, et al.
Journal of Controlled Release (2021) Vol. 335, pp. 557-574
Closed Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Augmenting Immunogenic Cell Death and Alleviating Myeloid‐Derived Suppressor Cells by Sono‐Activatable Semiconducting Polymer Nanopartners for Immunotherapy
Mengbin Ding, Yijing Zhang, Ningyue Yu, et al.
Advanced Materials (2023) Vol. 35, Iss. 33
Closed Access | Times Cited: 56
Enhancing in situ cancer vaccines using delivery technologies
Ningqiang Gong, Mohamad‐Gabriel Alameh, Rakan El‐Mayta, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 8, pp. 607-625
Closed Access | Times Cited: 25
Complex roles of autophagy in cancer development, immune evasion, and drug resistance
Xuegang Niu, Qi Sheng You, Kejun Hou, et al.
Drug Resistance Updates (2024) Vol. 78, pp. 101170-101170
Closed Access | Times Cited: 16
Regulation of Autophagy via Carbohydrate and Lipid Metabolism in Cancer
Javad Alizadeh, Mahboubeh Kavoosi, Navjit Singh, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2195-2195
Open Access | Times Cited: 37
Feedback loop between hypoxia and energy metabolic reprogramming aggravates the radioresistance of cancer cells
Shi Zheng, Cuilan Hu, Xiaogang Zheng, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Enhancing cancer immunotherapy: Nanotechnology-mediated immunotherapy overcoming immunosuppression
Yunna Chen, Qianqian Zhou, Zongfang Jia, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3834-3854
Open Access | Times Cited: 12
Polymeric indoximod based prodrug nanoparticles with doxorubicin entrapment for inducing immunogenic cell death and improving the immunotherapy of breast cancer
Xinlong Zang, Jinxiao Song, Yi Xie, et al.
Journal of Materials Chemistry B (2022) Vol. 10, Iss. 12, pp. 2019-2027
Closed Access | Times Cited: 28
Current Advances on Nanomaterials Interfering with Lactate Metabolism for Tumor Therapy
Qian Cheng, Xiao‐Lei Shi, Qilin Li, et al.
Advanced Science (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 22
Tumor-targeted self-assembled micelles reducing PD-L1 expression combined with ICIs to enhance chemo-immunotherapy of TNBC
Hongda Zhu, Kai Ma, Rui Ruan, et al.
Chinese Chemical Letters (2023) Vol. 35, Iss. 2, pp. 108536-108536
Closed Access | Times Cited: 18
Nanotherapeutics targeting autophagy regulation for improved cancer therapy
Yunmeng Liu, Yaxin Wang, Jincheng Zhang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2447-2474
Open Access | Times Cited: 7
Intelligent Delivery Systems in Tumor Metabolism Regulation: Exploring the Path Ahead
Xu‐Wen Li, Tao Sun, Chen Jiang
Advanced Materials (2023) Vol. 36, Iss. 11
Closed Access | Times Cited: 14
The recent progress of myeloid‐derived suppressor cell and its targeted therapies in cancers
Ruiyang Ren, Chenyi Xiong, R.C-S. Ma, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 13
Drug delivery for metabolism targeted cancer immunotherapy
Taravat Khodaei, Sahil Inamdar, Abhirami P. Suresh, et al.
Advanced Drug Delivery Reviews (2022) Vol. 184, pp. 114242-114242
Open Access | Times Cited: 22
Redox‐Responsive Polymeric Nanoparticle for Nucleic Acid Delivery and Cancer Therapy: Progress, Opportunities, and Challenges
Lei Xu, Yuan Cao, XU Ya, et al.
Macromolecular Bioscience (2023) Vol. 24, Iss. 3
Closed Access | Times Cited: 11
Intertumoral and intratumoral barriers as approaches for drug delivery and theranostics to solid tumors using stimuli-responsive materials
Karim Khanmohammadi Chenab, Haniyeh Malektaj, Ali Akbar Ranjbari Nadinlooie, et al.
Microchimica Acta (2024) Vol. 191, Iss. 9
Closed Access | Times Cited: 4
Nanoimmunotherapy: the smart trooper for cancer therapy
Suphiya Parveen, Dhanshree Vikrant Konde, Safal Kumar Paikray, et al.
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Nanotechnology-Based siRNA Delivery Systems to Overcome Tumor Immune Evasion in Cancer Immunotherapy
Kaili Deng, Dongxue Yang, Yuping Zhou
Pharmaceutics (2022) Vol. 14, Iss. 7, pp. 1344-1344
Open Access | Times Cited: 18
Stimuli‐responsive nanodelivery systems for amplifying immunogenic cell death in cancer immunotherapy
Wenhao Xu, Wangrui Liu, Jianfeng Yang, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 181-198
Closed Access | Times Cited: 10
Efficacy and Mechanism of a Biomimetic Nanosystem Carrying Doxorubicin and an IDO Inhibitor for Treatment of Advanced Triple-Negative Breast Cancer
Chuling Hu, Yan Liu, Wei Cao, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 507-526
Open Access | Times Cited: 3
Nanomaterials: leading immunogenic cell death-based cancer therapies
Changyu Ma, Zhe Cheng, Haotian Tan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
TAM‐Hijacked Immunoreaction Rescued by Hypoxia‐Pathway‐Intervened Strategy for Enhanced Metastatic Cancer Immunotherapy
Tianze Jiang, Bingjie Wang, Teng Wang, et al.
Small (2023) Vol. 20, Iss. 5
Closed Access | Times Cited: 6
Visible Light and Glutathione Dually Responsive Delivery of a Polymer-Conjugated Temozolomide Intermediate for Glioblastoma Chemotherapy
Ke Du, Qiuyu Xia, Jian Sun, et al.
ACS Applied Materials & Interfaces (2021) Vol. 13, Iss. 47, pp. 55851-55861
Closed Access | Times Cited: 14
Recent advances in targeting myeloid-derived suppressor cells and their applications to radiotherapy
Zi‐Zhan Li, Jing-Yu He, Qiuji Wu, et al.
International review of cell and molecular biology (2023), pp. 233-264
Closed Access | Times Cited: 5
Stimuli‐Responsive Nanocarriers as Active Enhancers of Antitumoral Immunotherapy
Jorge Parra‐Nieto, I. Aguirre de Cárcer, María Amor García del Cid, et al.
Advanced Materials Interfaces (2024)
Open Access | Times Cited: 1
Innovative lipid nanoparticles: A cutting-edge approach for potential renal cell carcinoma therapeutics
Asif Shahzad, Zhuoran Teng, Muhammad Arfat Yameen, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117465-117465
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top